Friday, 04 Dec 2020

Bangla Version

Govt signs deal with Beximco Pharma, India’s SII

No icon Pharmaceuticals

Health Desk- 06 Nov 2020: The government on Thursday signed a trilateral memorandum of understanding (MoU) with Beximco Pharmaceuticals Ltd and Serum Institute of India (SII) to collect three crore doses of Covid-19 vaccines from Serum.

Serum has an agreement with AstraZeneca to manufacture the vaccine, ChAdOx1 nCoV-19, being developed by the Oxford University. The vaccine has been named Covishield in India.

Once the vaccine is approved for human application, Beximco Pharma will buy each dose from Serum for $4 and then supply it to the government for $5.

The MoU was signed at the health ministry's conference room in the capital, in the presence of Health Minister Zahid Maleque and Indian High Commissioner Vikram K Doraiswami.

The health minister, in his speech, said, ‘We are signing this MoU under the condition that we will take it only if it is approved by the World Health Organization’.

The agreement was signed by Md Mostafa Kamal, additional secretary at the ministry, Rabbur Reza, chief operating officer of Beximco Pharmaceuticals Ltd, and Sandeep Malay, additional director of SII.

 

Most Read News